La Vista, Nebraska – Streck is pleased to announce the launch of CD-Chex™ Daily, the newest addition to the CD-Chex line of flow cytometry quality controls. CD-Chex Daily is a ready-to-use, assayed quality control designed to simplify and modernize daily QC workflows for flow cytometry laboratories.

CD-Chex Daily provides comprehensive coverage across 51 markers in a single vial, with markers spanning surface, intracellular and leukocyte scatter populations, including CD200, TRBC1, cMPO, CD27, CD81, CD79b CD36, cCD79a, CD79b, cKappa, cLambda and more, for broad panel support. CD-Chex Daily supports modern high-volume spectral cytometers and integrates seamlessly with Streck’s STATS® interlaboratory QC Program.

The control’s standardized assayed ranges meet CAP, CLIA, CLSI, and ISO 15189 requirements, limiting reliance on fragmented QC methods and supporting consistent comparability across instruments and overtime.

“”Labs have been asking for a single control that keeps pace with complex panels and modern instrumentation,” said Mirta Gamez, MT(ASCP), CLS, Associate Director of Hematology. “CD-Chex Daily delivers that — reducing costs, minimizing variability, and supporting compliance from day one.”

Supplied in a 3.0 mL pierceable plastic vial, available in single (Cat. No. 230695), two-pack (Cat. No. 230696), and five-pack (Cat. No. 230697) configurations, CD-Chex Daily provides 90-day closed-vial and 30-day open-vial stability to support labs of all testing volumes.

CD-Chex Daily is for Research Use Only. Not for use in diagnostic procedures.

About Streck, Inc. Established in 1971, Streck provides solutions that ensure every result counts by empowering clinical and research laboratories to reliably deliver accurate results, advance diagnostics and enable healthier, happier lives for patients everywhere. Streck products are manufactured in La Vista, Nebraska, and delivered to thousands of labs worldwide.